Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-8,842
Closed -$247K 1290
2016
Q4
$247K Sell
8,842
-4,168
-32% -$116K 0.01% 993
2016
Q3
$357K Sell
13,010
-3,098
-19% -$85K 0.01% 931
2016
Q2
$351K Buy
16,108
+30
+0.2% +$654 0.02% 681
2016
Q1
$359K Sell
16,078
-84,349
-84% -$1.88M 0.02% 636
2015
Q4
$2.78M Buy
100,427
+83,894
+507% +$2.32M 0.22% 166
2015
Q3
$427K Sell
16,533
-190,443
-92% -$4.92M 0.07% 434
2015
Q2
$5.13M Sell
206,976
-5,581
-3% -$138K 0.2% 170
2015
Q1
$5.36M Buy
212,557
+102,359
+93% +$2.58M 0.21% 145
2014
Q4
$2.58M Buy
+110,198
New +$2.58M 0.13% 328

Other funds holding QGENF

AHL Partners's QGENF Position: Q1 2017 in Review

AHL Partners sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 8,842 shares — an estimated $247K sold.

AHL Partners first reported a position in QGENF in Q4 2014 and held it in 9 quarters. The position peaked at $5.36M in Q1 2015. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • AHL Partners reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • AHL Partners sold 8,842 QIAGEN NV shares in Q1 2017, an estimated $247K.
  • AHL Partners first reported a position in QIAGEN NV in Q4 2014 and held it in 9 quarters.
  • AHL Partners's QIAGEN NV position peaked at $5.36M in Q1 2015.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on AHL Partners's 13F filing for Q1 2017, filed 15 May 2017.